chr2-111123848-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_138621.5(BCL2L11):c.103T>C(p.Ser35Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
BCL2L11
NM_138621.5 missense
NM_138621.5 missense
Scores
4
8
7
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
BCL2L11 (HGNC:994): (BCL2 like 11) The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The protein encoded by this gene contains a Bcl-2 homology domain 3 (BH3). It has been shown to interact with other members of the BCL-2 protein family and to act as an apoptotic activator. The expression of this gene can be induced by nerve growth factor (NGF), as well as by the forkhead transcription factor FKHR-L1, which suggests a role of this gene in neuronal and lymphocyte apoptosis. Transgenic studies of the mouse counterpart suggested that this gene functions as an essential initiator of apoptosis in thymocyte-negative selection. Several alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCL2L11 | NM_138621.5 | c.103T>C | p.Ser35Pro | missense_variant | 2/4 | ENST00000393256.8 | NP_619527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCL2L11 | ENST00000393256.8 | c.103T>C | p.Ser35Pro | missense_variant | 2/4 | 1 | NM_138621.5 | ENSP00000376943 | P1 | |
MIR4435-2HG | ENST00000645030.2 | n.453-86926A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.103T>C (p.S35P) alteration is located in exon 2 (coding exon 1) of the BCL2L11 gene. This alteration results from a T to C substitution at nucleotide position 103, causing the serine (S) at amino acid position 35 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.;.;.;.;.;.;.;D;T;.;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;L;L;L;L;L;L;L;L;L;.;L;L;L;.
MutationTaster
Benign
D;D;D;D;D;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;.;.;.;.;.;.;.;D;D;D;.;.;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;.;.;.;.;.;.;.;D;D;D;.;.;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;.;D
Polyphen
1.0, 0.99
.;D;.;D;.;.;.;D;.;.;.;D;.;D;.;.;.
Vest4
0.49, 0.51, 0.56, 0.53, 0.39, 0.41, 0.50, 0.47, 0.48, 0.51, 0.35, 0.49
MutPred
Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);Loss of phosphorylation at S35 (P = 0.0239);.;
MVP
MPC
0.35
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.